Paragonix Technologies Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025

Organ preservation company recognized for its innovations advancing the transplantation industry, ranking #6 in the healthcare category

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a leader in organ transplant technologies and organ procurement services, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones. Alongside the World’s 50 Most Innovative Companies, Fast Company recognizes 609 organizations across 58 sectors and regions.

To determine honorees, Fast Company’s editors and writers review companies driving progress around the world and across industries, evaluating thousands of submissions through a competitive application process. The result is a globe-spanning guide to innovation today, from early-stage startups to some of the most valuable companies in the world.

“Our list of the Most Innovative Companies offers both a comprehensive look at innovation today and a playbook for the future,” said Fast Company editor-in-chief Brendan Vaughan. “This year, we recognize companies that are harnessing AI in deep and meaningful ways, brands that are turning customers into superfans by overdelivering for them, and challengers that are introducing bold ideas and vital competition to their industries. At a time when the world is rapidly shifting, these companies are charting the way forward.”

As the first company to offer innovative, FDA-cleared and CE-marked preservation technologies across all solid organs, this recognition highlights Paragonix’s unwavering commitment to advancing transplant care. The company’s innovative devices are equipped to protect organs and monitor preservation conditions in real-time, leveraging advanced hypothermic preservation techniques that comply with recommended institutional guidelines and multi-year studies. By delivering comprehensive transplant support, Paragonix is dedicated to improving outcomes for thousands of patients awaiting life-saving organs.

In 2024, Paragonix made significant strides toward its mission by introducing new organ preservation devices–including the BAROguard®, PancreasPak®, and KidneyVault™, completing a strategic acquisition to drive global growth, and supporting groundbreaking transplants. The company has supported over 10,000 cases since 2018, and has been utilized at over 175 transplant centers across the world.

“For over seven decades, the transplant industry has faced an acute lack of innovation in preservation,” said Dr. Lisa Anderson, Founder and President of Paragonix Technologies. “Donor organs, the most precious of gifts representing a patient’s second chance of life, were transported in a common ice cooler because there was no other choice. We strove to change that. This prestigious award recognizes more than just our concentrated efforts to reshape the standard of care - it symbolizes how far the needle has shifted in transplant care in just a few short years.”

The full list of Fast Company’s Most Innovative Companies honorees can now be found at fastcompany.com. It will also be available on newsstands beginning March 25.

For more information about Paragonix Advanced Organ Preservation devices, please visit www.paragonix.com.

About FAST COMPANY

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with fellow business publication Inc. For more information, please visit fastcompany.com.

About Paragonix Technologies

Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Our FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ during transit. All Paragonix AOP devices are natively integrated with our novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution. For more information, visit www.paragonix.com.

Follow us on Twitter: @ParagonixSherpa
Connect with us on LinkedIn: Paragonix Technologies
Like Us on Facebook: Paragonix Technologies